The present invention relates to a vital melon (KCTC14699BP) and a composition comprising an extract thereof for preventing, treating or alleviating obesity or metabolic-related diseases. A vital melon of the present invention undergoes fruit setting such that the number of joints is the same as the number of main and side branches, and more fruit flesh can be obtained therefrom than from a conventional oriental melon, and thus excellent productivity is provided, and an extract thereof can effectively inhibit all of lipid accumulation, weight gain, fat accumulation in the liver, and the like, and thus can be effectively used as a composition for preventing, alleviating or treating obesity or various metabolic diseases.
The present invention relates to a composition for skin whitening which contains corn silk extract as an active ingredient. The composition of the present invention, by containing the corn silk extract as the active ingredient, inhibits melanogenesis in a melanocyte safely without cytotoxicity, inhibits expression of tyrosinase which is involved in melanin biosynthesis, and thereby can demonstrate an excellent skin whitening effect.
A61K 8/97 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés à base d’algues, de champignons, de lichens ou de plantesCosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés à base de leurs dérivés
A23L 1/30 - contenant des additifs (A23L 1/308 a priorité);;
A61Q 19/02 - Préparations pour les soins de la peau pour décolorer ou blanchir la peau chimiquement
A61Q 19/00 - Préparations pour les soins de la peau
4.
BITTER TASTE MASKED ORAL THIN FILM FORMULATION OF SILDENAFIL CITRATE
Bitter taste masked oral thin film formulations of sildenafil citrate that rapidly dissolve in the oral cavity, are disclosed. By preparing the fast-dissolving oral thin film of compositions, comprising bitter tasting sildenafil citrate and the bitter taste masking agent of sodium hydroxide, sodium bicarbonate or the mixtures thereof, this invention provides a formulation of an excellent fast-dissolving oral thin film which can mask the bitter taste of sildenafil citrate and thus mitigating an unpleasant feelings at time of drug administration.
This invention relates to composition for film with improved physical properties of edible film and its pharmaceutical preparation for film. This invention provides us with composition for edible film, which consists of hyroxypropyl methylcellulose(HPMC) and polyvinyl alcohol-polyethylene glycol copolymer(PVA-PEG copolymer) and pharmaceutical preparation for edible film containing drugs. Composition for edible film according to this invention enables us to manufacture intended edible film regardless of adding excipients in order to improve physical properties of film. Also, it has high performance on its physical properties, and enables us to manufacture edible film with high dissolution rate in the oral cavity. Furthermore, pharmaceutical preparation for edible film inhibits limitation on contents of drugs due to excipients, and enables us to manufacture pharmaceutical preparation for edible film containing various drugs without improving physical properties by using other excipients, and improves dosage compliance and convenience for various drugs.
The present invention relates to a pharmaceutical composition for preventing or treating hyperlipidemia, fatty liver, diabetes and obesity comprising a sesquiterpene derivative as an active ingredient. The sesquiterpene derivatives of the present invention leads to decrease in body fat weight, visceral fat weight and total cholesterol levels, triglyceride of plasma and liver tissue, blood glucose and blood insulin levels in a fast state, finally exhibiting efficacies on prevention or treatment of hyperlipidemia, fatty liver, diabetes and obesity.
The present invention relates to a pharmaceutical composition for preventing or treating hyperlipidemia, fatty liver, diabetes and obesity comprising a sesquiterpene derivative as an active ingredient. The sesquiterpene derivatives of the present invention leads to decrease in body fat weight, visceral fat weight and total cholesterol levels, triglyceride of plasma and liver tissue, blood glucose and blood insulin levels in a fast state, finally exhibiting efficacies on prevention or treatment of hyperlipidemia, fatty liver, diabetes and obesity.
The present invention relates to a novel compound, Juniperanol and compositions for preventing or treating hyperlipidemia, fatty liver, diabetes and obesity. In addition, the present invention relates to a composition for preventing or treating hyperlipidemia, fatty liver, diabetes or obesity, which comprises a fraction of a Juniper tree as an active ingredient, wherein the fraction is prepared by treating a porous adsorbent with an adsorbed extract of the Juniper tree with a mixed solvent of (i) a nonpolar solvent and (ii) water, ethanol, methanol or ethylacetate. The Juniperanol compound or fractions of this invention leads to decreases in body fat weight, visceral fat weight and total cholesterol levels, and increases in expression of UCP2 (uncoupling protein 2) or UCP3 (uncoupling protein 3) as well as prevention of insulin resistance, thereby exhibiting prominent prevention or treatment efficacies against hyperlipidemia, fatty liver, diabetes and obesity.
C07C 35/22 - Composés comportant au moins un groupe hydroxyle ou O-métal lié à un atome de carbone d'un cycle autre qu'un cycle aromatique à six chaînons polycycliques, avec au moins un groupe hydroxyle lié à un système cyclique condensé
A61K 36/14 - Cupressaceae (famille du cyprès), p. ex. genévrier ou cyprès
brevets
